Phase II study of individualized sunitinib as first-line therapy for metastatic renal cell cancer (mRCC).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 4555-4555 ◽  
Author(s):  
Georg A. Bjarnason ◽  
Jennifer J. Knox ◽  
Christian K. Kollmannsberger ◽  
Denis Soulieres ◽  
D. Scott Ernst ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
First Line ◽  
Metastatic Renal Cell Cancer ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data

2017 ◽  
Vol 28 ◽  
pp. v319
Author(s):  
G.A. Bjarnason ◽  
J. Knox ◽  
C.K. Kollmannsberger ◽  
D. Soulieres ◽  
D.S. Ernst ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Pharmacokinetic Data ◽  
First Line ◽  
Metastatic Renal Cell Cancer ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Phase Ii Study of Individualized Sunitinib As First-Line Therapy for Metastatic Clear Cell Renal Cell Cancer (Mrcc)

2014 ◽  
Vol 25 ◽  
pp. iv292 ◽  
Author(s):  
G.A. Bjarnason ◽  
B. Naveen ◽  
E. Winquist ◽  
C.K. Kollmannsberger ◽  
C. Canil ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Proteinuria with first-line therapy of metastatic renal cell cancer

2014 ◽  
Vol 22 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Josiah D Land ◽  
Adrienne H Chen ◽  
Bradley J Atkinson ◽  
Diana H Cauley ◽  
Nizar M Tannir
Keyword(s):  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer ◽  
First Line ◽  
Metastatic Renal Cell Cancer ◽  
First Line Therapy ◽  
Line Therapy

A phase II study of dovitinib (TKI258), an FGFR- and VEGFR-inhibitor, in patients with advanced or metastatic renal cell cancer (mRCC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 4551-4551 ◽  
Author(s):  
E. Angevin ◽  
V. Grünwald ◽  
A. Ravaud ◽  
D. E. Castellano ◽  
C. C. Lin ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Metastatic Renal Cell Cancer ◽  
Vegfr Inhibitor

A-PREDICT: A phase II study of axitinib in patients with metastatic renal cell cancer unsuitable for nephrectomy (CRUKE/11/061).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS4597-TPS4597
Author(s):  
Rosalie A. Fisher ◽  
Andrew Rowan ◽  
Mark Stares ◽  
Mark F Webster-Smith ◽  
Rebecca Lewis ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Metastatic Renal Cell Cancer

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

2007 ◽  
Vol 8 (11) ◽  
pp. 975-984 ◽  
Author(s):  
Olivier Rixe ◽  
Ronald M Bukowski ◽  
M Dror Michaelson ◽  
George Wilding ◽  
Gary R Hudes ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Metastatic Renal Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document